[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
chevron_left

Relapsed and Refractory MM Treatment

adjust

1. What is relapsed myeloma and refractory myeloma? Video

bookmark_border

2. What is progressive disease? Is it the same as relapse? Video

bookmark_border

3. What is a Biochemical vs Clinical Relapse? Video

bookmark_border

4. What are the cycles of relapse and remission in myeloma? Video

bookmark_border

5. Why do drugs stop working? Video

bookmark_border

6. Do individuals become refractory to a given drug or an entire class of drugs? Video

bookmark_border

7. What testing should be done at relapse? What is restaging? Video

bookmark_border

8. What are the goals of treatment at relapse? Video

bookmark_border

9. With relapsed myeloma, when should you modify current therapy change dosage? Video

bookmark_border

10. What are the NCCN Treatment Guidelines? What strategy should be used in selecting a therapy? Video

bookmark_border

11. Why is it important to be consulting with a myeloma specialist at relapse? Video

bookmark_border

12. What treatments are available for first relapse? Video

bookmark_border

13. What treatments should be considered in bortezomib/velcade refractory patients at first relapse? Video

bookmark_border

14. What are some possible monoclonal antibodies and MAB combinations to consider at first relapse? Video

bookmark_border

15. What are some newer therapies with different mechanisms of action to consider at first relapse? Video

bookmark_border

16. What does it mean to be triple class refractory? Video

bookmark_border

17. Is there a role for transplant if not used upfront or a second transplant at first relapse? Video

bookmark_border

18. What is the role of genomics at relapse? Video

bookmark_border

19. Are there any targeted approaches for specific genetic subsets that patients should ask about? Video

bookmark_border

20. How do you decide on an appropriate treatment at relapse with so many to choose from? Video

bookmark_border

21. When should a patient consider a clinical trial in relapse? Video

bookmark_border

22. With so many options available, at what point should a patient consider getting a second opinion? Video

bookmark_border

23. What FDA approved treatments are available treatments for patients with RRMM with received two or more prior lines of therapy? Video

bookmark_border

24. What is meant by t-cell redirecting therapy? Video

bookmark_border

25. Where should CAR T cell therapy be positioned in RRMM approved and trials? Video

bookmark_border

26. Where should bispecific antibodies be positioned in RRMM? Video

bookmark_border

27. What factors should be considered when choosing between a CAR T cell therapy and a bispecific antibody therapy? Video

bookmark_border

28. What is a BCMA-Directed Therapy? What are Some FDA Approved BCMA Directed Therapies? Video

bookmark_border

29. Is There a Role for Conventional Chemotherapy in the treatment of Relapsed and Refractory Myeloma? Video

bookmark_border

30. Will an Allogeneic Transplant ever be Considered at Relapse? Video

bookmark_border

31. What are Some Promising Investigational Agents and Novel Therapies for Relapsed/Refractory Patients? Video

bookmark_border

32. What is the Role of Supportive Care throughout Relapsed and Refractory Myeloma Management? Video

bookmark_border

33. What is Bone Strengthening Therapy? Video

bookmark_border

34. What are Some Tips for Coping with the Fear of Relapse? Video

bookmark_border

35. What are the Unmet Needs and Challenges in the Relapsed/Refractory Myeloma setting? Video

bookmark_border

36. How can HealthTree help with assessing treatment options at relapse? Video

bookmark_border

37. What is Off-label Use of a Drug? Video

bookmark_border

38. (Guest Lecture): Immunotherapies | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video

bookmark_border

38. What is Considered a Line of Therapy? Video

bookmark_border

39. (Guest Lecture): Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022 Video

bookmark_border

40. (Guest Lecture): Amyloidosis | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video

bookmark_border

41. (Guest Lecture) When and How you Become Refractory to a Drug and How to Find the Best Next Treatment Video

bookmark_border

42. (Guest Lecture): Emerging Treatments | Experts Discuss Relapsed/Refractory Myeloma, Amyloidosis Video

bookmark_border

43. (Guest Lecture): September 2023 - Personalizing Options for Relapse/Refractory Patients Video

bookmark_border

44. (Guest Lecture): October 2023 - Personalizing Therapy for Each Relapsed/Refractory Myeloma Patient Video

bookmark_border

45. (Guest Lecture): March 2024 - The Bounty of Treatments for Early Relapsed Myeloma Video

bookmark_border

46. (Guest Lecture): March 2024 - Exploring the Myeloma Toolbox Video

bookmark_border

What is relapsed myeloma and refractory myeloma?

Last year